SPDR S&P Biotech Etf (Xbi) Stake Increased by Bank of New York Mellon Corp


Bank of New York Mellon Corp lifted its stake in shares of SPDR S&P Biotech ETF by 12.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 21,214 shares of the exchange traded fund's stock after buying an additional 2,282 shares during the quarter.



from Biotech News